Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Entourage Health Corp V.ENTG

Alternate Symbol(s):  ETRGF

Entourage Health Corp. is a Canada-based license holder producing and distributing cannabis products for both the medical and adult-use markets. The Company owns and operates a 26,000 square feet indoor facility in Aylmer, Ontario (the Aylmer Facility), specializing in product development and fulfillment for both adult-use and medical cannabis. The Company is focused on building a portfolio of brands in the Canadian market, including its brand Color Cannabis, mainstream brand Saturday Cannabis, medical cannabis product brand Starseed Medicinal and its craft cannabis brand Syndicate Cannabis. The Company produces a diverse portfolio of cannabis and cannabis derivative products, including oils, capsules, soft chews, topicals, beverages and vapes, for sale in both the medical and adult-use markets across Canada. Its elite adult-use product portfolio also includes Dime Bag a pre-roll offering, sold across eight provincial distribution agencies.


TSXV:ENTG - Post by User

Bullboard Posts
Comment by Zanderron Apr 16, 2019 11:25am
114 Views
Post# 29633203

RE:Financials

RE:FinancialsUnfortunately nobody has any insight into the potential numbers but WMD themselves. Recently everyone has been trying to forecast financials and have been way off....for APHA and TRST etc and it has been a huge flop. Setting reasonable expectations needs to be the key. You numbers seem reasonable. GLTA
Walterthedog wrote: Any guesses what's to come? I think the market will be happy with anything over 5M$. 4M$ and under may be considered a miss. At 6 or 7, we could even show a modest profit. I haven't seen any guidance but they had 5M$ in inventory and roughly 5M$ in bio assets (it mentions that they have 924 572g as expected yield from growing plants which should yield around 4.5M$ in gross sales). probably retain most of their med sales equating to 2M$ plus trying to satisfy all their provincial agreements and possibly even bulk sales to other LPs as Kieth had hinted? My guess is 5M$ gross rev with a small net loss but a large gain in bio assets (+8M$) giving us an eps of roughly .07$/share and setting up nicely for end of May's financials


Bullboard Posts